Literature DB >> 862573

Biopsy and cytology in the diagnosis of early gastric cancer: 10-year experience with direct vision techniques at a Japanese institution.

S Kobayashi, Y Yoshii, T Kasugai.   

Abstract

The results of direct vision biopsy and cytology for the diagnosis of early gastric cancer during the periods from 1964 to 1969 and from 1970 to 1974 were compared. From 1964 to 1969 the diagnostic accuracy of gastric biopsy was 94.7% at the initial examination and 97.3% in the final diagnosis, while washing cytology under direct vision gave a diagnostic accuracy of 83.0% at the first washing and 93.3% in the final cytologic diagnosis. Because of such a high yield of gastric biopsy, it was the procedure of the first choice from 1970 to 1974, giving a diagnostic accuracy of 96.7% at the initial examination and 99.4% in the final biopsy diagnosis with only one suspicious case. The cytologic examination by brushing has, therefore, become supplementary to biopsy in cases where a stenosis proximal to a tumor obscures the definitive tissue.

Entities:  

Mesh:

Year:  1977        PMID: 862573     DOI: 10.1055/s-0028-1098376

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  4 in total

1.  Diagnosis of metastatic lesions to the stomach by salvage cytology. A report of three cases.

Authors:  L K Green; S Zachariah; D Y Graham
Journal:  Dig Dis Sci       Date:  1990-11       Impact factor: 3.199

2.  Endoscopic needle aspiration cytology: a new method for the diagnosis of upper gastrointestinal cancer.

Authors:  C J Ingoldby; M K Mason; R I Hall
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

3.  [Biopsy and cytology in the diagnosis and treatment of surgical diseases (author's transl)].

Authors:  K Elster
Journal:  Langenbecks Arch Chir       Date:  1977-11

4.  Early gastric cancer. 21-year experience.

Authors:  W L Bringaze; C W Chappuis; P Correa; I Cohn
Journal:  Ann Surg       Date:  1986-08       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.